ID ALDR_PIG Reviewed; 316 AA. AC P80276; DT 01-FEB-1994, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 02-SEP-2026, entry version 164. DE RecName: Full=Aldo-keto reductase family 1 member B1; DE EC=1.1.1.21 {ECO:0000250|UniProtKB:P15121}; DE EC=1.1.1.300 {ECO:0000250|UniProtKB:P15121}; DE EC=1.1.1.372 {ECO:0000250|UniProtKB:P15121}; DE EC=1.1.1.54 {ECO:0000250|UniProtKB:P15121}; DE AltName: Full=Aldehyde reductase; DE AltName: Full=Aldose reductase; DE Short=AR; GN Name=AKR1B1; Synonyms=ALR2; OS Sus scrofa (Pig). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus. OX NCBI_TaxID=9823; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RX PubMed=8493902; DOI=10.1007/978-1-4615-2904-0_28; RA Kubiseski T.J., Green N.C., Flynn T.G.; RT "Location of an essential arginine residue in the primary structure of pig RT aldose reductase."; RL Adv. Exp. Med. Biol. 328:259-265(1993). RN [2] RP PROTEIN SEQUENCE OF 2-316, ACETYLATION AT ALA-2, AND MASS SPECTROMETRY. RC TISSUE=Lens; RX PubMed=8281941; DOI=10.1111/j.1432-1033.1993.tb18445.x; RA Jaquinod M., Potier N., Klarskov K., Reymann J.-M., Sorokine O., RA Kieffer S., Barth P., Andriantomanga V., Biellmann J.-F., RA van Dorsselaer A.; RT "Sequence of pig lens aldose reductase and electrospray mass spectrometry RT of non-covalent and covalent complexes."; RL Eur. J. Biochem. 218:893-903(1993). RN [3] RP X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS). RX PubMed=1734286; DOI=10.1038/355469a0; RA Rondeau J.-M., Tete-Favier F., Podjarny A., Reymann J.-M., Barth P., RA Biellmann J.-F., Moras D.; RT "Novel NADPH-binding domain revealed by the crystal structure of aldose RT reductase."; RL Nature 355:469-472(1992). RN [4] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS). RX PubMed=9195881; DOI=10.1016/s0969-2126(97)00216-5; RA Urzhumtsev A., Tete-Favier F., Mitschler A., Barbanton J., Barth P., RA Urzhumtseva L., Biellmann J.-F., Podjarny A.D., Moras D.; RT "A 'specificity' pocket inferred from the crystal structures of the RT complexes of aldose reductase with the pharmaceutically important RT inhibitors tolrestat and sorbinil."; RL Structure 5:601-612(1997). CC -!- FUNCTION: Catalyzes the NADPH-dependent reduction of a wide variety of CC carbonyl-containing compounds to their corresponding alcohols. Displays CC enzymatic activity towards endogenous metabolites such as aromatic and CC aliphatic aldehydes, ketones, monosaccharides, bile acids and CC xenobiotics substrates. It catalyzes the reduction of glucose to CC sorbitol, the first step of the polyol pathway, an alternative route of CC glucose metabolism that converts glucose to fructose. This pathway CC becomes highly active under elevated glucose levels, such as during CC hyperglycemia. Reduces steroids and their derivatives and CC prostaglandins. Displays low enzymatic activity toward all-trans- CC retinal, 9-cis-retinal, and 13-cis-retinal. Catalyzes the reduction of CC diverse phospholipid aldehydes such as 1-palmitoyl-2-(5-oxovaleroyl)-sn CC -glycero-3-phosphoethanolamin (POVPC) and related phospholipid CC aldehydes that are generated from the oxydation of phosphotidylcholine CC and phosphatdyleethanolamides. Plays a role in detoxifying dietary and CC lipid-derived unsaturated carbonyls, such as crotonaldehyde, 4- CC hydroxynonenal, trans-2-hexenal, trans-2,4-hexadienal and their CC glutathione-conjugates carbonyls (GS-carbonyls). CC {ECO:0000250|UniProtKB:P15121}. CC -!- CATALYTIC ACTIVITY: CC Reaction=an alditol + NADP(+) = an aldose + NADPH + H(+); CC Xref=Rhea:RHEA:12789, Rhea:RHEA-COMP:9554, Rhea:RHEA-COMP:9555, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15693, ChEBI:CHEBI:17522, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.21; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:12791; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=D-sorbitol + NADP(+) = D-glucose + NADPH + H(+); CC Xref=Rhea:RHEA:59924, ChEBI:CHEBI:4167, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:17924, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:59926; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=erythritol + NADP(+) = D-erythrose + NADPH + H(+); CC Xref=Rhea:RHEA:59928, ChEBI:CHEBI:15378, ChEBI:CHEBI:17113, CC ChEBI:CHEBI:27904, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=xylitol + NADP(+) = D-xylose + NADPH + H(+); CC Xref=Rhea:RHEA:27445, ChEBI:CHEBI:15378, ChEBI:CHEBI:17151, CC ChEBI:CHEBI:53455, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-arabinitol + NADP(+) = L-arabinose + NADPH + H(+); CC Xref=Rhea:RHEA:25229, ChEBI:CHEBI:15378, ChEBI:CHEBI:17535, CC ChEBI:CHEBI:18403, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.21; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=galactitol + NADP(+) = D-galactose + NADPH + H(+); CC Xref=Rhea:RHEA:37967, ChEBI:CHEBI:4139, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:16813, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.21; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ribitol + NADP(+) = D-ribose + NADPH + H(+); CC Xref=Rhea:RHEA:59932, ChEBI:CHEBI:15378, ChEBI:CHEBI:15963, CC ChEBI:CHEBI:47013, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-gulonate + NADP(+) = aldehydo-D-glucuronate + NADPH + H(+); CC Xref=Rhea:RHEA:14909, ChEBI:CHEBI:13115, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:142686; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=all-trans-retinol + NADP(+) = all-trans-retinal + NADPH + CC H(+); Xref=Rhea:RHEA:25033, ChEBI:CHEBI:15378, ChEBI:CHEBI:17336, CC ChEBI:CHEBI:17898, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC EC=1.1.1.300; Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=9-cis-retinol + NADP(+) = 9-cis-retinal + NADPH + H(+); CC Xref=Rhea:RHEA:54916, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, CC ChEBI:CHEBI:58349, ChEBI:CHEBI:78272, ChEBI:CHEBI:78273; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=13-cis-retinol + NADP(+) = 13-cis-retinal + NADPH + H(+); CC Xref=Rhea:RHEA:54920, ChEBI:CHEBI:15378, ChEBI:CHEBI:45479, CC ChEBI:CHEBI:45487, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=glycerol + NADP(+) = D-glyceraldehyde + NADPH + H(+); CC Xref=Rhea:RHEA:23592, ChEBI:CHEBI:15378, ChEBI:CHEBI:17378, CC ChEBI:CHEBI:17754, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC EC=1.1.1.372; Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=glycerol + NADP(+) = L-glyceraldehyde + NADPH + H(+); CC Xref=Rhea:RHEA:38111, ChEBI:CHEBI:15378, ChEBI:CHEBI:17754, CC ChEBI:CHEBI:27975, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC EC=1.1.1.372; Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=benzyl alcohol + NADP(+) = benzaldehyde + NADPH + H(+); CC Xref=Rhea:RHEA:59944, ChEBI:CHEBI:15378, ChEBI:CHEBI:17169, CC ChEBI:CHEBI:17987, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=prenol + NADP(+) = 3-methyl-2-butenal + NADPH + H(+); CC Xref=Rhea:RHEA:58420, ChEBI:CHEBI:15378, ChEBI:CHEBI:15825, CC ChEBI:CHEBI:16019, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(E)-hex-2-en-1-ol + NADP(+) = (E)-hex-2-enal + NADPH + H(+); CC Xref=Rhea:RHEA:58424, ChEBI:CHEBI:15378, ChEBI:CHEBI:28913, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:141205; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(E,E)-2,4-hexadien-1-ol + NADP(+) = (E,E)-2,4-hexadienal + CC NADPH + H(+); Xref=Rhea:RHEA:58428, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:82334, CC ChEBI:CHEBI:142625; Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a 4-hydroxynonen-1-ol + NADP(+) = a 4-hydroxynonenal + NADPH + CC H(+); Xref=Rhea:RHEA:58336, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, CC ChEBI:CHEBI:58349, ChEBI:CHEBI:142593, ChEBI:CHEBI:142606; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=prostaglandin F2alpha + NADP(+) = prostaglandin H2 + NADPH + CC H(+); Xref=Rhea:RHEA:45312, ChEBI:CHEBI:15378, ChEBI:CHEBI:57404, CC ChEBI:CHEBI:57405, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=allyl alcohol + NADP(+) = acrolein + NADPH + H(+); CC Xref=Rhea:RHEA:12168, ChEBI:CHEBI:15368, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:16605, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.54; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=pyridine 3-methanol + NADP(+) = pyridine-3-carbaldehyde + CC NADPH + H(+); Xref=Rhea:RHEA:58776, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:28345, ChEBI:CHEBI:45213, ChEBI:CHEBI:57783, CC ChEBI:CHEBI:58349; Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-(5-oxopentanoyl)-sn-glycero-3-phosphocholine CC + NADPH + H(+) = 1-hexadecanoyl-2-(5-hydroxypentanoyl)-sn-glycero-3- CC phosphocholine + NADP(+); Xref=Rhea:RHEA:58512, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:77890, CC ChEBI:CHEBI:142747; Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-(7-oxoheptanoyl)-sn-glycero-3-phosphocholine CC + NADPH + H(+) = 1-hexadecanoyl-2-(7-hydroxyheptanoyl)-sn-glycero-3- CC phosphocholine + NADP(+); Xref=Rhea:RHEA:58752, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:134601, CC ChEBI:CHEBI:142748; Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-(9-oxononanoyl)-sn-glycero-3-phosphocholine + CC NADPH + H(+) = 1-hexadecanoyl-2-(9-hydroxynonanoyl)-sn-glycero-3- CC phosphocholine + NADP(+); Xref=Rhea:RHEA:58592, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:61042, CC ChEBI:CHEBI:142749; Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- CATALYTIC ACTIVITY: CC Reaction=1-hexadecanoyl-2-(5-oxopentanoyl)-sn-glycero-3- CC phosphoethanolamine + NADPH + H(+) = 1-hexadecanoyl-2-(5- CC hydroxypentanoyl)-sn-glycero-3-phosphoethanolamine + NADP(+); CC Xref=Rhea:RHEA:58756, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, CC ChEBI:CHEBI:58349, ChEBI:CHEBI:142750, ChEBI:CHEBI:142751; CC Evidence={ECO:0000250|UniProtKB:P15121}; CC -!- ACTIVITY REGULATION: Cys-299 acts as a redox-sensitive regulatory site. CC Its thiol group undergoes reversible oxidative and nitrosative CC modifications (S-nitrosylation, S-glutathiolation) that modulate enzyme CC activity, linking AKR1B1 function to the cellular redox environment. CC Tolrestat inhibits retinal reduction. {ECO:0000250|UniProtKB:P15121}. CC -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P15121}. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- MASS SPECTROMETRY: Mass=35778; Mass_error=3; Method=Electrospray; CC Evidence={ECO:0000269|PubMed:8281941}; CC -!- SIMILARITY: Belongs to the aldo/keto reductase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L14950; AAA30989.1; -; mRNA. DR EMBL; U46065; AAC48515.1; -; mRNA. DR PIR; A59021; A59021. DR RefSeq; NP_001001539.1; NM_001001539.2. DR PDB; 1AH0; X-ray; 2.30 A; A=2-316. DR PDB; 1AH3; X-ray; 2.30 A; A=2-316. DR PDB; 1AH4; X-ray; 2.00 A; A=2-316. DR PDB; 1DLA; X-ray; 3.00 A; A/B/C/D=3-316. DR PDB; 1EKO; X-ray; 2.20 A; A=2-316. DR AlphaFoldDB; P80276; -. DR MDposit; P80276; -. DR SMR; P80276; -. DR FunCoup; P80276; 1494. DR STRING; 9823.ENSSSCP00000064633; -. DR BindingDB; P80276; -. DR ChEMBL; CHEMBL4559; -. DR DrugCentral; P80276; -. DR iPTMnet; P80276; -. DR PaxDb; 9823-ENSSSCP00000064633; -. DR PeptideAtlas; P80276; -. DR GeneID; 396816; -. DR KEGG; ssc:396816; -. DR CTD; 231; -. DR eggNOG; KOG1577; Eukaryota. DR HOGENOM; CLU_023205_0_0_1; -. DR InParanoid; P80276; -. DR OrthoDB; 416253at2759; -. DR SABIO-RK; P80276; -. DR EvolutionaryTrace; P80276; -. DR PRO; PR:P80276; -. DR Proteomes; UP000008227; Unplaced. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0004032; F:aldose reductase (NADPH) activity; ISS:UniProtKB. DR GO; GO:0052650; F:all-trans-retinol dehydrogenase (NADP+) activity; ISS:UniProtKB. DR GO; GO:0047655; F:allyl-alcohol dehydrogenase activity; ISS:UniProtKB. DR GO; GO:0047681; F:aryl-alcohol dehydrogenase (NADP+) activity; IEA:RHEA. DR GO; GO:0032866; F:D-xylose reductase (NADPH) activity; IEA:RHEA. DR GO; GO:0047956; F:glycerol dehydrogenase (NADP+) activity; ISS:UniProtKB. DR GO; GO:0032867; F:L-arabinose reductase (NADPH) activity; IEA:RHEA. DR GO; GO:0047939; F:L-glucuronate reductase activity; IEA:RHEA. DR GO; GO:0036130; F:prostaglandin H2 endoperoxidase reductase activity; ISS:UniProtKB. DR GO; GO:0001758; F:retinal dehydrogenase (NAD+) activity; ISS:UniProtKB. DR GO; GO:0006060; P:D-sorbitol metabolic process; ISS:UniProtKB. DR GO; GO:0001523; P:retinoid metabolic process; ISS:UniProtKB. DR CDD; cd19107; AKR_AKR1B1-19; 1. DR FunFam; 3.20.20.100:FF:000009; Aldo-keto reductase family 1 member B1; 1. DR Gene3D; 3.20.20.100; NADP-dependent oxidoreductase domain; 1. DR InterPro; IPR020471; AKR. DR InterPro; IPR018170; Aldo/ket_reductase_CS. DR InterPro; IPR036812; NAD(P)_OxRdtase_dom_sf. DR InterPro; IPR023210; NADP_OxRdtase_dom. DR PANTHER; PTHR11732; ALDO/KETO REDUCTASE; 1. DR Pfam; PF00248; Aldo_ket_red; 1. DR PIRSF; PIRSF000097; AKR; 1. DR PRINTS; PR00069; ALDKETRDTASE. DR SUPFAM; SSF51430; NAD(P)-linked oxidoreductase; 1. DR PROSITE; PS00798; ALDOKETO_REDUCTASE_1; 1. DR PROSITE; PS00062; ALDOKETO_REDUCTASE_2; 1. DR PROSITE; PS00063; ALDOKETO_REDUCTASE_3; 1. DR PDBsum; 1AH0; -. DR PDBsum; 1AH3; -. DR PDBsum; 1AH4; -. DR PDBsum; 1DLA; -. DR PDBsum; 1EKO; -. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cytoplasm; Direct protein sequencing; KW Lipid metabolism; NADP; Oxidoreductase; Phosphoprotein; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:8281941" FT CHAIN 2..316 FT /note="Aldo-keto reductase family 1 member B1" FT /id="PRO_0000124625" FT ACT_SITE 49 FT /note="Proton donor" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 20 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 21 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 22 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 44 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 49 FT /ligand="alpha-D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:58225" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 160 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 161 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 211 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 213 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 215 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 263 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 264 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 265 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 266 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 269 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 272 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 273 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250|UniProtKB:P15121" FT BINDING 299 FT /ligand="alpha-D-glucose 6-phosphate" FT /ligand_id="ChEBI:CHEBI:58225" FT /evidence="ECO:0000250|UniProtKB:P15121" FT SITE 78 FT /note="Lowers pKa of active site Tyr" FT /evidence="ECO:0000250" FT SITE 299 FT /note="Redox-sensitive site" FT /evidence="ECO:0000250|UniProtKB:P15121" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000269|PubMed:8281941" FT MOD_RES 3 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P07943" FT MOD_RES 222 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P15121" FT MOD_RES 263 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P15121" FT CONFLICT 99 FT /note="D -> N (in Ref. 1; AAA30989/AAC48515)" FT /evidence="ECO:0000305" FT STRAND 4..6 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 12..16 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 25..38 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 42..44 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 47..49 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 52..64 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 70..72 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 74..79 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 81..83 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 86..88 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 89..100 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 105..110 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 118..120 FT /evidence="ECO:0007829|PDB:1EKO" FT STRAND 129..131 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 138..151 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 153..155 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 157..161 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 164..171 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 181..186 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 194..203 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 206..210 FT /evidence="ECO:0007829|PDB:1AH4" FT STRAND 223..225 FT /evidence="ECO:0007829|PDB:1AH0" FT HELIX 228..230 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 232..241 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 245..255 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 267..272 FT /evidence="ECO:0007829|PDB:1AH4" FT TURN 273..278 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 283..290 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 302..304 FT /evidence="ECO:0007829|PDB:1AH4" FT HELIX 311..313 FT /evidence="ECO:0007829|PDB:1AH4" SQ SEQUENCE 316 AA; 35868 MW; 7218B663AC1B4E92 CRC64; MASHLVLYTG AKMPILGLGT WKSPPGKVTE AVKVAIDLGY RHIDCAHVYQ NENEVGLGLQ EKLQGQVVKR EDLFIVSKLW CTDHEKNLVK GACQTTLRDL KLDYLDLYLI HWPTGFKPGK DPFPLDGDGN VVPDESDFVE TWEAMEELVD EGLVKAIGVS NFNHLQVEKI LNKPGLKYKP AVNQIEVHPY LTQEKLIEYC KSKGIVVTAY SPLGSPDRPW AKPEDPSLLE DPRIKAIAAK YNKTTAQVLI RFPMQRNLIV IPKSVTPERI AENFQVFDFE LSPEDMNTLL SYNRNWRVCA LMSCASHKDY PFHEEY //